CD34 and melanoma: This is in contrast to melanoma (Wiersma et al., 2012), colon carcinoma (Wiersma et al., 2015), and CD34+ AML stem cells (Choukrani et al., 2023), where Gal-9 had no effect towards their healthy counterparts.